Financial Performance - Operating revenue for Q1 2024 was ¥41,495,463.91, representing a 27.55% increase year-over-year from ¥32,532,319.86[12] - Net profit attributable to shareholders for Q1 2024 was ¥9,612,269.55, an 11.56% increase from ¥8,616,278.92 in the same period last year[12] - The net profit after deducting non-recurring gains and losses surged by 149.84% to ¥8,058,309.17 compared to ¥3,225,385.03 in Q1 2023[12] - Total operating revenue for Q1 2024 reached ¥41,495,463.91, a 27.5% increase from ¥32,532,319.86 in Q1 2023[34] - Net profit attributable to shareholders increased to ¥7,594,678.80 in Q1 2024, compared to ¥3,647,636.59 in Q1 2023, reflecting a growth of 108.1%[34] - The company's net profit for the first quarter of 2024 reached CNY 5,428,973.40, a decrease from CNY 8,528,642.77 in the same period of 2023, representing a decline of approximately 36.8%[38] - Operating revenue for the first quarter of 2024 was CNY 16,198,825.45, compared to CNY 32,467,375.97 in the first quarter of 2023, indicating a decrease of about 50.1%[38] - The total profit for the first quarter of 2024 was CNY 5,923,655.10, down from CNY 9,786,175.67 in the first quarter of 2023, reflecting a decline of approximately 39.0%[39] - The company's operating profit for the first quarter of 2024 was CNY 4,832,706.07, compared to CNY 8,646,479.50 in the same period of 2023, a decrease of about 44.5%[39] Cash Flow and Assets - The company's cash flow from operating activities showed a significant decline of 327.69%, resulting in a net outflow of ¥10,861,820.75 due to slower sales collections[14] - Cash and cash equivalents stood at CNY 108,050,100.50, down from CNY 113,410,090.71[27] - The cash flow from operating activities for the first quarter of 2024 was negative at CNY -10,861,820.75, contrasting with a positive cash flow of CNY 4,770,420.90 in the first quarter of 2023[40] - The total cash inflow from operating activities in the first quarter of 2024 was CNY 19,938,651.55, down from CNY 33,797,855.57 in the first quarter of 2023, a decrease of approximately 41.0%[40] - Cash inflow from operating activities totaled 19,285,239.35 CNY in Q1 2024, significantly lower than 32,709,050.00 CNY in Q1 2023, highlighting a decline in sales performance[42] - The ending balance of cash and cash equivalents was 107,991,904.82 CNY for Q1 2024, down from 112,874,751.85 CNY in Q1 2023[43] Research and Development - Research and development expenses increased by 43.43% to ¥2,924,117.09, reflecting the company's commitment to enhancing product competitiveness[13] - Research and development expenses for Q1 2024 were ¥2,924,117.09, up from ¥2,038,706.24 in Q1 2023, indicating a focus on innovation[34] - Research and development expenses for the first quarter of 2024 amounted to CNY 1,035,734.64, down from CNY 2,038,706.24 in the first quarter of 2023, a reduction of approximately 49.2%[39] Investment and Assets - Investment income surged by 988.48% to ¥1,577,310.57, primarily due to increased returns from Huzhou Anda investments[14] - The total assets of the company as of March 31, 2024, amounted to CNY 526,550,600.17, an increase from CNY 523,785,655.39 as of December 31, 2023[27] - The company's current assets totaled CNY 365,122,224.55, slightly down from CNY 367,941,688.71 at the end of 2023[27] - The company's non-current assets increased to CNY 161,428,375.62 from CNY 155,843,966.68[28] - The total liabilities decreased to CNY 71,650,931.98 from CNY 78,114,367.05, indicating improved financial stability[28] - The accounts receivable rose by 18.62% to ¥109,738,633.85, attributed to slower customer payments influenced by market conditions[13] - The accounts receivable increased to CNY 111,628,785.67 from CNY 95,436,424.67, reflecting higher sales or credit terms[27] Compliance and Legal Matters - There were no significant legal disputes or financial guarantees reported during the period[23] - The company has no pledged shares or judicially frozen shares among its major shareholders[21] - The company has committed to previously disclosed promises, ensuring compliance with regulatory requirements[23] Overall Financial Health - The asset-liability ratio for the consolidated entity improved to 13.61%, down from 14.91% at the end of 2023[12] - The company's equity position remains strong with total equity reflecting a healthy balance sheet[28] - Shareholders' equity increased to ¥444,263,894.12 as of March 31, 2024, from ¥438,169,601.16 at the end of 2023[33]
丰安股份(870508) - 2024 Q1 - 季度财报